The US Food and Drug Administration has reduced requirements for preclinical animal testing, leading to a surge of interest in organoids, tissue chips and in silico testing.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Computational Modelling Enabling In Silico Trials for Cardiac Physiologic Pacing
Journal of Cardiovascular Translational Research Open Access 23 October 2023
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Moutinho, S. Researchers and regulators plan for a future without lab animals. Nat Med 29, 2151–2154 (2023). https://doi.org/10.1038/s41591-023-02362-z
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-023-02362-z
This article is cited by
-
Reverse translation: the key to increasing the clinical success of immunotherapy?
Genes & Immunity (2023)
-
Computational Modelling Enabling In Silico Trials for Cardiac Physiologic Pacing
Journal of Cardiovascular Translational Research (2023)